AIM Total Assets vs Short Term Debt Analysis
0A4Y Stock | 0.23 0.01 4.55% |
AIM ImmunoTech financial indicator trend analysis is way more than just evaluating AIM ImmunoTech prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether AIM ImmunoTech is a good investment. Please check the relationship between AIM ImmunoTech Total Assets and its Short Term Debt accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AIM ImmunoTech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more information on how to buy AIM Stock please use our How to Invest in AIM ImmunoTech guide.
Total Assets vs Short Term Debt
Total Assets vs Short Term Debt Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of AIM ImmunoTech Total Assets account and Short Term Debt. At this time, the significance of the direction appears to have strong contrarian relationship.
The correlation between AIM ImmunoTech's Total Assets and Short Term Debt is -0.63. Overlapping area represents the amount of variation of Total Assets that can explain the historical movement of Short Term Debt in the same time period over historical financial statements of AIM ImmunoTech, assuming nothing else is changed. The correlation between historical values of AIM ImmunoTech's Total Assets and Short Term Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Assets of AIM ImmunoTech are associated (or correlated) with its Short Term Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Short Term Debt has no effect on the direction of Total Assets i.e., AIM ImmunoTech's Total Assets and Short Term Debt go up and down completely randomly.
Correlation Coefficient | -0.63 |
Relationship Direction | Negative |
Relationship Strength | Weak |
Total Assets
Total assets refers to the total amount of AIM ImmunoTech assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in AIM ImmunoTech books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Short Term Debt
Most indicators from AIM ImmunoTech's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into AIM ImmunoTech current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AIM ImmunoTech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more information on how to buy AIM Stock please use our How to Invest in AIM ImmunoTech guide.Selling General Administrative is likely to drop to about 8 M in 2024
AIM ImmunoTech fundamental ratios Correlations
Click cells to compare fundamentals
AIM ImmunoTech Account Relationship Matchups
High Positive Relationship
High Negative Relationship
AIM ImmunoTech fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 14.2M | 13.8M | 20.8M | 64.6M | 74.3M | 78.0M | |
Total Current Liabilities | 5.3M | 1.1M | 1.1M | 673K | 605.7K | 575.4K | |
Total Stockholder Equity | 8.7M | 5.2M | 13.4M | 61.3M | 70.5M | 74.0M | |
Retained Earnings | (318.6M) | (327.6M) | (342.0M) | (361.1M) | (325.0M) | (341.2M) | |
Cash | 1.4M | 299K | 1.5M | 38.5M | 44.3M | 46.5M | |
Other Assets | 1.4M | 1.9M | 748K | 1.3M | 1.2M | 1.1M | |
Cash And Short Term Investments | 2.1M | 1.8M | 8.8M | 39.0M | 44.9M | 47.1M | |
Short Term Investments | 695K | 1.5M | 7.3M | 501K | 576.2K | 547.3K | |
Capital Surpluse | 317.4M | 323.7M | 340.2M | 402.5M | 462.9M | 374.0M | |
Total Liab | 5.5M | 8.7M | 7.3M | 3.3M | 3.8M | 6.2M | |
Total Current Assets | 3.8M | 10.4M | 40.3M | 50.2M | 57.7M | 60.6M | |
Intangible Assets | 858K | 912K | 1.2M | 1.5M | 1.7M | 1.2M | |
Common Stock | 1K | 10K | 42K | 48K | 55.2K | 29.0K | |
Property Plant Equipment | 7.8M | 7.3M | 6.7M | 4.2M | 3.8M | 5.9M | |
Other Liab | 1.1M | 57K | 180K | 35K | 31.5K | 29.9K | |
Net Tangible Assets | 4.3M | 11.5M | 59.1M | 54.2M | 62.3M | 65.4M | |
Accounts Payable | 680K | 472K | 383K | 198K | 178.2K | 169.3K | |
Net Receivables | 1.1M | 820K | 1.1M | 1.6M | 1.9M | 1.0M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for AIM Stock Analysis
When running AIM ImmunoTech's price analysis, check to measure AIM ImmunoTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AIM ImmunoTech is operating at the current time. Most of AIM ImmunoTech's value examination focuses on studying past and present price action to predict the probability of AIM ImmunoTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AIM ImmunoTech's price. Additionally, you may evaluate how the addition of AIM ImmunoTech to your portfolios can decrease your overall portfolio volatility.